These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 33728760)

  • 21. Telehealth and Medicare Type 2 Diabetes Care Outcomes: Evidence From Louisiana.
    Walker B; Stoecker C; Shao Y; Nauman E; Fort D; Shi L
    Med Care; 2023 Apr; 61(Suppl 1):S77-S82. PubMed ID: 36893422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of urgently initiated tele-prescription due to COVID-19 on glycemic control in patients with type 2 diabetes.
    Park SD; Kim NY; Jeon JH; Kim JG; Lee IK; Park KG; Choi YK
    Korean J Intern Med; 2021 Jul; 36(4):942-948. PubMed ID: 34092049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between telemedicine use and diabetes risk factor assessment and control in a primary care network.
    Grauer A; Duran AT; Liyanage-Don NA; Torres-Deas LM; Metser G; Moise N; Kronish IM; Ye S
    J Endocrinol Invest; 2022 Sep; 45(9):1749-1756. PubMed ID: 35596919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of a prolonged lockdown and utilization of diabetes telemedicine on cardiometabolic health in people with diabetes during the COVID-19 outbreak in Saudi Arabia.
    Al-Sofiani ME; AlMesned RK; Bafadel MS; Alguwaihes AM; Alfadda AA
    Prim Care Diabetes; 2022 Oct; 16(5):644-649. PubMed ID: 35773134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient Satisfaction With Telemedicine During the COVID-19 Pandemic: Retrospective Cohort Study.
    Ramaswamy A; Yu M; Drangsholt S; Ng E; Culligan PJ; Schlegel PN; Hu JC
    J Med Internet Res; 2020 Sep; 22(9):e20786. PubMed ID: 32810841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Living and working environments are important determinants of glycemic control in patients with diabetes during the COVID-19 pandemic: A retrospective observational study.
    Terakawa A; Bouchi R; Kodani N; Hisatake T; Sugiyama T; Matsumoto M; Ihana-Sugiyama N; Ohsugi M; Ueki K; Kajio H
    J Diabetes Investig; 2022 Jun; 13(6):1094-1104. PubMed ID: 35088564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modification effect of receipt of diabetes care on the association between COVID-19 infection and HbA1c level during the first year of the coronavirus pandemic using a nationwide population-based database.
    Okada A; Yamaguchi S; Ono S; Kurakawa KI; Yasunaga H; Nangaku M; Yamauchi T; Kadowaki T
    J Diabetes Investig; 2024 Jul; 15(7):953-963. PubMed ID: 38429979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of COVID-19 lockdown on glycemic control in type 1 diabetes.
    Duarte V; Mota B; Ferreira S; Costa C; Correia CC
    Arch Pediatr; 2022 Jan; 29(1):27-29. PubMed ID: 34955306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of COVID-19 Lockdown on Glycemic Control in Patients with Type 2 Diabetes Mellitus in Dubai.
    Makki I; Alnoon N; Rahmani N; Almulla J; Alamiri A; Alfalasi A; Zidan M
    Curr Diabetes Rev; 2022; 18(8):e081221198650. PubMed ID: 34879807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the COVID-19 pandemic on glycemic control in Brazilian patients with type 2 diabetes.
    Tannus LRM; Zapelini RM; Cabizuca CA; Abi-Abib RC; Matheus ASM; Calassara PC; Pozzan R; Cobas RA
    Endocrine; 2022 Sep; 77(3):455-460. PubMed ID: 35838896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of an mHealth-enabled hierarchical diabetes management intervention in primary care in China (ROADMAP): A cluster randomized trial.
    Jia W; Zhang P; Zhu D; Duolikun N; Li H; Bao Y; Li X;
    PLoS Med; 2021 Sep; 18(9):e1003754. PubMed ID: 34547030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacist telehealth in an underserved urban population with type 2 diabetes mellitus.
    Mukherjee SM; DelDotto D; Patel A; Silva MA
    Res Social Adm Pharm; 2023 Nov; 19(11):1465-1470. PubMed ID: 37507339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetes care practices and outcomes in 40.000 children and adolescents with type 1 diabetes from the SWEET registry during the COVID-19 pandemic.
    Chobot A; Lanzinger S; Alkandari H; Todd Alonso G; Blauensteiner N; Coles N; De Sanctis L; Mul D; Saboo B; Smart C; Tsai MC; Zabeen B; Dovc K
    Diabetes Res Clin Pract; 2023 Aug; 202():110809. PubMed ID: 37385473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantifying Worsened Glycemic Control During the COVID-19 Pandemic.
    Ledford CJW; Roberts C; Whisenant E; Walters C; Akamiro K; Butler J; Ali A; Seehusen DA
    J Am Board Fam Med; 2021 Feb; 34(Suppl):S192-S195. PubMed ID: 33622837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Race- and Neighborhood-Related Disparities Spanning the COVID-19 Pandemic: Trajectories of Combined Glycemic Control and BMI in Youth With Diabetes.
    Vajravelu ME; Mani I; Malik S; Hewitt B; Peyyety V; Arslanian S
    Diabetes Care; 2023 Mar; 46(3):511-518. PubMed ID: 36534444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of the COVID-19 pandemic on the glycemic control in people with diabetes mellitus: A retrospective cohort study.
    Ohkuma K; Sawada M; Aihara M; Doi S; Sekine R; Usami S; Ohe K; Kubota N; Yamauchi T
    J Diabetes Investig; 2023 Aug; 14(8):985-993. PubMed ID: 37118898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between postprandial hyperglycemia at clinic visits and all-cause and cancer mortality in patients with type 2 diabetes: A long-term historical cohort study in Japan.
    Takao T; Takahashi K; Suka M; Suzuki N; Yanagisawa H
    Diabetes Res Clin Pract; 2019 Feb; 148():152-159. PubMed ID: 30641172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time trends (2012-2020) in glycated hemoglobin and adherence to the glycemic targets recommended for elderly patients by the Japan Diabetes Society/Japan Geriatrics Society Joint Committee among memory clinic patients with diabetes mellitus.
    Sugimoto T; Noma H; Kuroda Y; Matsumoto N; Uchida K; Kishino Y; Saji N; Niida S; Sakurai T
    J Diabetes Investig; 2022 Dec; 13(12):2038-2046. PubMed ID: 36124721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telemedicine for the Underserved Racial and Ethnic Minorities During COVID-19 and Beyond.
    Sarwal A; Lim J; Sarwal A
    Telemed J E Health; 2024 Jun; 30(6):1588-1593. PubMed ID: 38739446
    [No Abstract]   [Full Text] [Related]  

  • 40. Telemedicine for the management of diabetic patients in a high-complexity Latin American hospital.
    Casas LA; Alarcón J; Urbano A; Peña-Zárate EE; Sangiovanni S; Libreros-Peña L; Escobar MF
    BMC Health Serv Res; 2023 Mar; 23(1):314. PubMed ID: 36997918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.